CEO: Peter M. Hecht / Mark Mallon

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Ironwood Pharmaceuticals Inc is a biotechnology company which is focused on advancing innovative product opportunities in areas of large unmet needs such as constipation, gastrointestinal disorders, hyperuricemia, among others.


Key numbers

Market Capitalization:1975906800
Shares Outstanding: 156818000
Float: 151934374
Next Earning Date:2020-02-13
TTm EPS: -0.2723
TTm Dividend Rate:
200 days moving average:10.77
50 days moving average: 12.5
One day percent Change: -0.87



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,